Loading...
LifeTech Scientific Corporation
LFTSF•PNK
Healthcare
Medical - Devices
$0.23
$0.00(0.00%)

The company's financials show resilient growth, with revenue advancing from $319.75M in Q2 2023 to $652.83M in Q2 2024. Gross profit remained healthy with margins at 79% in Q2 2024 compared to 79% in Q2 2023. Operating income hit $202.006M last quarter, sustaining a consistent 31% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $208.48M. Net income rose to $205.56M, while earnings per share reached $0.05. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan